Genetic testing can identify mutations in the PAH gene, which is responsible for producing phenylalanine hydroxylase. This information can help predict the severity of PKU and tailor treatment plans. In the context of toxicology, understanding genetic variations can provide insights into the variability of phenylalanine toxicity among different individuals.
